Table 1.

Patient demographics and clinical findings

	Immediate (n = 34)	Historical (n = 18)	P
Sex			0.580
Male	20 (59%)	6 (33.3%)
Female	14 (41%)	12 (66.6%)
Mean age (years)	58.4	57.6	0.688
Indication
Malignancy	28 (82.4%)	11 (61.1%)
Osteoradionecrosis	3 (8.8%)	4 (22.2%)
Defect following previous surgery	3 (8.8%)	3 (17%)
Primary tumour type			0.060
Squamous cell carcinoma	19 (67.9%)	5 (45.5%)
Ameloblastoma	4 (14.3%)	1 (9.1%)
Osteosarcoma	3 (10.7%)	2 (18.2%)
Adenoid cystic carcinoma	1 (3.6%)	0 (0%)
Spindle cell carcinoma	1 (3.6%)	0 (0%)
Basal cell carcinoma	0 (0%)	1 (9.1%)
Mucoepidermoid carcinoma	0 (0%)	2 (18.2%)
T classification			0.579
T1	0 (0%)	1 (9.1%)
T2	2 (7.1%)	0 (0%)
T3	1 (3.6%)	0 (0%)
T4	18 (64.3%)	7 (63.6%)
N/A	7 (25%)	3 (27.3%)
History of prior head and neck malignancy			0.495
Yes	5 (14.7%)	4 (22.2%)
No	29 (85.3%)	14 (77.8%)
Smoking			0.006
Yes	5 (14.7%)	9 (50.0%)
No	29 (85.3%)	9 (50.0%)
Diabetes			0.674
Yes	3 (8.8%)	1 (5.5%)
No	31 (91.2%)	17 (94.5%)
Bone flap used for reconstruction			0.896
Fibula	29 (85.3%)	14 (77.8%)
Deep circumflex iliac artery	4 (11.8%)	2 (11.1%)
Scapula	1 (2.9%)	2 (11.1%)
Bone flap laterality			0.111
Right	16 (47.1%)	5 (27.8%)
Left	18 (52.9%)	13 (72.2%)
Number of bone segments used			0.527
1	10 (29.4%)	7 (38.9%)
2	16 (47.1%)	8 (44.4%)
3	8 (23.5%)	2 (11.1%)
4	0 (0%)	1 (5.5%)